(became mute and inactive) on placebo, and recovered quickly on reserpine; the placebo periods were therefore made short ( i o to I 5 days) with this patient, and urine was collected every day (compare below). In the day-time the patients took part in the usual ward activities. Sleep was nearly always normal.
All the patients lived on ordinary hospital food and were allowed to eat and drink water ad libitum. The doses of reserpine varied from 3 to 6 mg. pro die.
METHODS
Urine was collected both day and night. Urine passed just after the patients got out of bed in the morning was counted as night excretion and usually made up the whole night sample. The last part of the day sample was taken just before the patients went to bed.
Except for patient E.M. (see above) urine was collected two or three times a week (each time over 24 hours). The first four days of a medicine or placebo period were regarded as transitional and not included in the calculation of the period-means.
Sodium and potassium were determined by flame-photometry with a Beckman DU appara tus with photo-multiplier (acetylene-oxygen gas). Creatinine was determined by the picric acid method and VMA by high-voltage paper electrophoresis (Randrup, 1962 ). Table I shows a comprehensive survey of our data on urine volume. It will be seen that under reserpine there was an increase in the night volume of urine, while the changes in the day volume were small and without a consistent trend
RESULTS
The day/night ratio was therefore decreased, while the 24 hours' volume was increased.
We have evaluated the statistical significance of these changes by following the horizontal rows of Table I . This shows that the day/night ratio changed in the same direction (upwards by shifts from reserpine to placebo and down wards by shifts from placebo to reserpine) in I 7 out of the i8 shifts shown in Table I . Likewise the 24 h. volume changed in the same direction in I 7 of the x8 shifts. The probability of getting this high degree of regularity by mere chance is extremely small. Some of the patients tended to go to bed earlier with reserpine than with placebo, which might be imagined to contribute to the change in the day/night ratio. Table I, determinations were also made of creatinine, sodium, potassium, and 4-hydrOxy-3-methoxymandeic acid (VMA) in the urine.
Changes in the concentrations of these substances were observed, which tended to preserve the diurnal rhythm of their excretion in spite of the changes of urine volume induced by reserpine. These â€oe¿ compensatoryâ€• changes were seen most clearly with VMA (see Table II errors are nearly the same as those of Table I .) The compensation was also clear with potassium and creatinine, while sodium showed only little compensation. The diurnal rhythm of sodium excretion was, therefore, changed by reserpine in similar manner as that of the volume.
DIscussIoN
The increase in 24 h. urine volume found in our experiments may appear surprising on the background of repeated reports of antidiuretic action of reserpine in both man and animals (Chaudhury et al., 1962; Khazan et al., 1962; Gaddum et al., 1958 , with further references). Gaddum et al. (1958) thus found that reserpine caused a sharp decrease in the urine volume of schizophrenic patients; in their investigation, however, the fluid intake was kept constant, while there were no restrictions in our patients' eating and drinking. It would therefore appear, Table I. as well as weight gain are reported as side effects of reserpine treatment, see e.g. Andersen et al. (â€˜957), pp. â€˜¿ 9, 37, 47, 57; Wing (1956) Kline, 1955; Goldman, 1956; Miner, 1955, p. 147; Marley and Pare, 1956; Huchtemann and Pflugfelder, 1955; Liebaldt, 1958) . The change in the diurnal rhythm of urine excretion caused by reserpine is not so readily understood. It should be noted, however, that abnormalities and spontaneous changes in both urine volume and diurnal rhythm are reported also in unmedicated psychotic patients (Gjessing, see e.g. fig. 15, p. 389, in the 1936 report; Hoskins, 1946, see pp. 155 and 158) . In this connection it may be noted that in our small group of five patients we have one (0.0.) with an extremely large 24 h. urine volume under placebo and one (E.M.) with an extremely small one. Yet in spite of these large differences in the placebo baseline values the effect of reserpine is the same in all patients.
Five schizophrenic patients were studied under prolonged treatment with reserpine alternating with placebo. In the reserpine periods the 24 h. urine volume was increased, while the day/night ratio for the urine volume was decreased. The effect of reserpine upon the day/night ratio for the urinary excretion and concentration of various urine solids is also reported.
The results are discussed in relation to the literature. The reported antidiuretic effectof reserpine isparticularly considered.
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